跳到正文
原文
Nature 健康护理主题·· 11 天前AI 评分35

骨质疏松患者术前使用双膦酸盐与术后神经认知相关结果的全国倾向评分匹配队列研究

Association between preoperative bisphosphonate therapy and postoperative neurocognitive-related outcomes in osteoporosis: a nationwide propensity score–matched cohort study

AI 导读

该研究通过全国倾向评分匹配队列分析,发现骨质疏松患者术前使用双膦酸盐与术后谵妄、抗精神病药物使用、神经认知恢复延迟及精神病或行为综合征的风险降低相关,同时减少重症监护病房入院、急诊就诊和再入院次数。研究结果提示,双膦酸盐可能有助于改善骨质疏松患者术后的神经认知相关结果和降低医疗资源使用。

正文

Scientific Reports (2026) Cite this article

We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

Abstract

Postoperative neurocognitive complications are common in older surgical patients. These complications are associated with prolonged recovery and increased healthcare utilization, highlighting the importance of identifying modifiable perioperative factors. Although osteoporosis may coexist with cognitive vulnerability, evidence linking preoperative bisphosphonate therapy to postoperative neurocognitive outcomes remains limited. We conducted a nationwide propensity score–matched cohort study using TriNetX data from adults with osteoporosis undergoing surgery in the United States between 2005 and 2025. Bisphosphonate exposure was defined by prescriptions recorded within 90 days before surgery, with a 365-day ascertainment window for zoledronic acid. The primary outcome was delirium within 30 days after surgery. Secondary outcomes included antipsychotic initiation, delayed neurocognitive recovery, and psychotic or behavioral syndromes. Among 228,662 matched pairs, bisphosphonate therapy was associated with lower risks of delirium (relative risk [RR]: 0.38, 95% confidence interval [CI]: 0.30–0.48), antipsychotic initiation (RR: 0.40, 95% CI: 0.36–0.43), delayed neurocognitive recovery (RR: 0.76, 95% CI: 0.66–0.86; all p < 0.0001), and psychotic or behavioral syndromes (RR: 0.60, 95% CI: 0.45–0.81; p = 0.0006). Bisphosphonate use was also associated with lower risks of intensive care unit admission, emergency department visits, and hospital readmission. Preoperative bisphosphonate therapy was associated with lower risks of recorded postoperative neurocognitive outcomes and lower healthcare utilization in surgical patients with osteoporosis. Residual confounding and outcome under-ascertainment warrant cautious interpretation.

Acknowledgements

None.

Funding

This work was supported by a grant from National Science and Technology Council (NSTC115-2314-B-038-131), Taipei, Taiwan.

Author information

Author notes

  1. These authors contributed equally: Yi-Chien Wang and Hsiang-Ling Wu.

Authors and Affiliations

  1. Department of Anesthesiology, Shuang Ho Hospital, Taipei Medical University, 291, Zhongzheng Road, Zhonghe District, New Taipei City, 23561, Taiwan

    Yi-Chien Wang, Jui-Tai Chen, Yih-Giun Cherng & Ying-Hsuan Tai

  2. Department of Anesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, 11031, Taiwan

    Yi-Chien Wang, Jui-Tai Chen, Yih-Giun Cherng & Ying-Hsuan Tai

  3. Department of Anesthesiology, Taipei Veterans General Hospital, Taipei, 11217, Taiwan

    Hsiang-Ling Wu

  4. School of Medicine, National Yang Ming Chiao Tung University, Taipei, 11221, Taiwan

    Hsiang-Ling Wu

  5. Department of Anesthesiology and Perioperative Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 409, Houston, TX, 77030, USA

    Juan Pablo Cata

Authors

  1. Yi-Chien Wang
  2. Hsiang-Ling Wu
  3. Juan Pablo Cata
  4. Jui-Tai Chen
  5. Yih-Giun Cherng
  6. Ying-Hsuan Tai

Corresponding author

Correspondence to Ying-Hsuan Tai.

Ethics declarations

Competing interests

The authors declare no competing interests.

Ethics approval and consent to participate

This study was approved by the Joint Institutional Review Board of Taipei Medical University (TMU-JIRB, Approval No. N202412077; date of approval: December 25, 2024). Given the retrospective nature of the study, the requirement for informed consent was waived by the TMU-JIRB.

Consent for publication

Not applicable.

Prior Presentations

Not applicable.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, YC., Wu, HL., Cata, J.P. et al. Association between preoperative bisphosphonate therapy and postoperative neurocognitive-related outcomes in osteoporosis: a nationwide propensity score–matched cohort study. Sci Rep (2026). https://doi.org/10.1038/s41598-026-80129-5

Download citation

  • Received: 06 May 2026

  • Accepted: 05 November 2026

  • Published: 09 November 2026

  • DOI: https://doi.org/10.1038/s41598-026-80129-5

Keywords

来源:Nature 健康护理主题 · nature.com